Patient lab report with high levels of cholesterol and prescription bottle. Photo: iStock Boston, MA –(ENEWSPF)–July 14, 2015. A new study from Harvard T.H. Chan School of Public Health researchers has found that it would be cost-effective to treat 48-67% of all adults aged 40-75 in the U.S. with cholesterol-lowering[Read More…]
Health and Fitness
FDA Approves Targeted Therapy for First-line Treatment of Patients with a Type of Metastatic Lung Cancer
Companion test also approved to identify appropriate patients Silver Spring, Maryland–(ENEWSPF)–July 14, 2015. The U.S. Food and Drug Administration yesterday approved Iressa (gefitinib) for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors harbor specific types of epidermal growth factor receptor (EGFR) gene mutations, as[Read More…]
New NIH Brochure Highlights the Value of Palliative Care for Children Living with Serious Illnesses
The National Institute of Nursing Research releases the publication as part of their Palliative Care: Conversations Matter campaign Bethesda, Maryland–(ENEWSPF)–July 14, 2015. A new brochure from the National Institute of Nursing Research (NINR), a component of the National Institutes of Health, provides information about pediatric palliative care — a type[Read More…]
Remarks by President Obama at White House Conference on Aging
Washington, DC–(ENEWSPF)–July 13, 2015 – 11:12 A.M. EDT THE PRESIDENT: Hello, everybody. (Applause.) Thank you so much. Thank you. (Applause.) Everybody, please have a seat. Welcome to the White House Conference on Aging, everybody. And please give Vicki a big round of applause for the outstanding work she’s doing to[Read More…]
Bipartisan Group of Senators Requests GAO Report on Medicaid Oversight and Quality of Care in Assisted Living Facilities
WASHINGTON, DC –(ENEWSPF)–July 13, 2015. A bipartisan group of United States senators has sent a letter to the Government Accountability Office (GAO) requesting a report on the oversight of and quality of care provided to Medicaid enrollees at assisted living facilities. The letter was sent by Senators Elizabeth Warren (D-Mass.),[Read More…]
U.S. Senators Ask Federal Agencies About Efforts to Facilitate Medical Marijuana Research
WASHINGTON, DC –(ENEWSPF)–July 13, 2015. A group of eight United States senators today sent a letter to the U.S. Department of Health and Human Services (HHS), the Office of National Drug Control Policy (ONDCP), and the Drug Enforcement Administration (DEA) requesting information about the agencies’ efforts to facilitate and coordinate[Read More…]
Cholera Cases Multiply as Cost of Clean Water Skyrockets in South Sudan Capital: Oxfam
LONDON–(ENEWSPF)–13 July 2015. Cholera cases are rapidly increasing in South Sudan’s capital, Juba, as the cost of clean water skyrockets amid a worsening economic crisis. 33 people have died in Juba alone including seven children under five, with 700 more people infected with the deadly and contagious disease. Zlatko Gegic,[Read More…]
Anti-GMO Labeling Bill Just Keeps Getting DARKer
WASHINGTON –(ENEWSPF)–July 13, 2015. This week the House Agriculture Committee is expected to mark up and vote on a bill that would take away the right of states to label food with genetically modified ingredients, or GMOs. According to EWG, the latest draft of the measure shows it to be[Read More…]
Rep. Givson: ‘We Need to do Better’ for Lyme Disease
Washington, DC–(ENEWSPF)–July 13, 2015. The House of Representatives has passed the 21st Century Cures Act, a sweeping medical research bill that makes specific provisions for Lyme disease. New York Congressman Chris Gibson mentioned Lyme disease in his one-minute speech asking Congress to approve the measure. View the video at: http://www.c-span.org/video/?c4543892/rep-chris-gibson-speaks-support-hr-6-21st-century-cures-act[Read More…]
FDA Approves New Drug to Treat Schizophrenia and as an Add on to an Antidepressant to Treat Major Depressive Disorder
Silver Spring, Maryland–(ENEWSPF)–July 13, 2015. On July 10, the U.S. Food and Drug Administration approved Rexulti (brexpiprazole) tablets to treat adults with schizophrenia and as an add-on treatment to an antidepressant medication to treat adults with major depressive disorder (MDD). Schizophrenia is a chronic, severe, and disabling brain disorder affecting[Read More…]





